Roth, Arnaud D <br/><br/>
Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Jan 2010 
 - 466-74 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1527-7755 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2009.23.3452  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--diagnosis<br/>Adolescent<br/>Adult<br/>Aged<br/>Colonic Neoplasms--diagnosis<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Mutation<br/>Prognosis<br/>Prospective Studies<br/>Proto-Oncogene Mas<br/>Proto-Oncogene Proteins--genetics<br/>Proto-Oncogene Proteins B-raf--genetics<br/>Proto-Oncogene Proteins p21(ras)<br/>Young Adult<br/>ras Proteins--genetics